These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 8823321

  • 1. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
    Salloum E, Doria R, Schubert W, Zelterman D, Holford T, Roberts KB, Farber LR, Kiehl RK, Cardinale J, Cooper DL.
    J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
    [Abstract] [Full Text] [Related]

  • 2. Second solid malignancies after combined modality therapy for Hodgkin's disease.
    Doria R, Holford T, Farber LR, Prosnitz LR, Cooper DL.
    J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incidence of second cancers in patients treated for Hodgkin's disease.
    Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P.
    J Natl Cancer Inst; 1995 May 17; 87(10):732-41. PubMed ID: 7563150
    [Abstract] [Full Text] [Related]

  • 5. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.
    Blood; 1996 May 01; 87(9):3625-32. PubMed ID: 8611686
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL, Tucker MA, Hoppe RT.
    J Natl Cancer Inst; 1993 Jan 06; 85(1):25-31. PubMed ID: 8416252
    [Abstract] [Full Text] [Related]

  • 7. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
    van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD, Burgers JM, Somers R.
    J Natl Cancer Inst; 1995 Oct 18; 87(20):1530-7. PubMed ID: 7563187
    [Abstract] [Full Text] [Related]

  • 8. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R.
    J Clin Oncol; 1994 Feb 18; 12(2):312-25. PubMed ID: 8113838
    [Abstract] [Full Text] [Related]

  • 9. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 18; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 10. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
    Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD.
    Int J Radiat Oncol Biol Phys; 2003 Jan 01; 55(1):36-43. PubMed ID: 12504034
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD, González FA, Villegas A, del Potro E, Díaz Mediavilla J, Martínez R, Alvarez A, Colomé JA.
    Sangre (Barc); 1992 Dec 01; 37(6):429-33. PubMed ID: 1293793
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT, Ha CS, Hagemeister FB, Fuller LM, Rodriguez MA, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):609-16. PubMed ID: 9336140
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E, Baio A, Orlandi E, Arcaini L, Passamonti F, Griva V, Casagrande W, Pascutto C, Franchini P, Lazzarino M.
    Clin Cancer Res; 2006 Nov 01; 12(21):6487-93. PubMed ID: 17085663
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C, Veraguth A, Lütolf UM.
    Strahlenther Onkol; 1994 Mar 01; 170(3):140-6. PubMed ID: 8160093
    [Abstract] [Full Text] [Related]

  • 19. Second cancers following pediatric Hodgkin's disease.
    Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS.
    J Clin Oncol; 1998 Feb 01; 16(2):536-44. PubMed ID: 9469338
    [Abstract] [Full Text] [Related]

  • 20. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
    Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF, Boice JD, Gilbert E.
    J Natl Cancer Inst; 2002 Feb 06; 94(3):182-92. PubMed ID: 11830608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.